Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Collaborative Research and Development Grants

University of Guelph

$50,000.00

Bovine complement component C3d as an adjuvant to facilitate early calfhood vaccination

FY 2008-09

Summary
Newborns of all species are exquisitely susceptible to infection; thus, nature has provided for immediate passive immunity by transfer of maternal antibodies (MatAb) across the placenta (humans) or in colostrum (calves). Even so, this may be inadequate if the dam has not mounted a strong antibody response herself, or in calves, if the newborn fails to ingest sufficient colostrum. Early induction of active immunity by vaccination would ensure protection for calves with low MatAb and provide continuity of immunity for those with higher passive titres. To achieve this, innovative approaches are needed since induction of active immunity in neonates is compromised both by immaturity of the immune system and, ironically, by down regulation due to MatAb. In natural infection, the protein complement component C3 binds irreversibly to potential pathogens, and the bound fragment, C3d, enhances immune response by reacting with receptors on cells that present antigens to the immune system and on antibody producing B cells. Experimentally, the threshold for B cell activation was reduced 10,000 fold in mice when multiple C3ds were bound to vaccine antigens. To investigate C3d's potential to enhance active immunity in neonatal calves, we have cloned and sequenced the gene coding for bovine C3d and expressed the recombinant protein (BoC3d) in several forms. Neonatal calves have low serum C3, but BoC3d bound to vaccine antigens may compensate for limited natural C3, and could override suppressive signals from MatAb. Initially, we will use fluorescence activated cell scan (FACs) to document changes in expression of receptors for C3d on B cells as calves age, to assess activation of B cells in response to BoC3d complexes, and to evaluate the effects of MatAb on B cell function in the presence of BoC3d. Constructs with optimal activity will then be tested for capacity to enhance active immunity in neonatal calves. As a model, we use vaccine containing C3d and the leukotoxin (Lkt) of Mannheimia haemolytica, a common bovine pathogen. Its role in calfhood pneumonia makes this a relevant target for study and our extensive experience with Lkt facilitates assessment of immune response and vaccine efficacy.
Program
Collaborative Research and Development Grants
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
349680-2006
Name nom
Shewen, Patricia
Department département
Pathobiology
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2008
Competition year année de concours
2006
Award amount
50000
Program id
CRDPJ
Program nane en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1209
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Agriculture
Area of application fr
Agriculture
Research subject code
5512
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Veterinary sciences
Research subject fr
Médecine vétérinaire
Partie
2
Nb partie
3
Application title
Bovine complement component C3d as an adjuvant to facilitate early calfhood vaccination
Keyword
NA
Application summary
Newborns of all species are exquisitely susceptible to infection; thus, nature has provided for immediate passive immunity by transfer of maternal antibodies (MatAb) across the placenta (humans) or in colostrum (calves). Even so, this may be inadequate if the dam has not mounted a strong antibody response herself, or in calves, if the newborn fails to ingest sufficient colostrum. Early induction of active immunity by vaccination would ensure protection for calves with low MatAb and provide continuity of immunity for those with higher passive titres. To achieve this, innovative approaches are needed since induction of active immunity in neonates is compromised both by immaturity of the immune system and, ironically, by down regulation due to MatAb. In natural infection, the protein complement component C3 binds irreversibly to potential pathogens, and the bound fragment, C3d, enhances immune response by reacting with receptors on cells that present antigens to the immune system and on antibody producing B cells. Experimentally, the threshold for B cell activation was reduced 10,000 fold in mice when multiple C3ds were bound to vaccine antigens. To investigate C3d's potential to enhance active immunity in neonatal calves, we have cloned and sequenced the gene coding for bovine C3d and expressed the recombinant protein (BoC3d) in several forms. Neonatal calves have low serum C3, but BoC3d bound to vaccine antigens may compensate for limited natural C3, and could override suppressive signals from MatAb. Initially, we will use fluorescence activated cell scan (FACs) to document changes in expression of receptors for C3d on B cells as calves age, to assess activation of B cells in response to BoC3d complexes, and to evaluate the effects of MatAb on B cell function in the presence of BoC3d. Constructs with optimal activity will then be tested for capacity to enhance active immunity in neonatal calves. As a model, we use vaccine containing C3d and the leukotoxin (Lkt) of Mannheimia haemolytica, a common bovine pathogen. Its role in calfhood pneumonia makes this a relevant target for study and our extensive experience with Lkt facilitates assessment of immune response and vaccine efficacy.
University of Guelph - $50,000 Grant (2008-09) | Canada Spends